The knockout of ALKBH5 in CRC cells was capable of enhancing the efficacy of immunotherapy and prolonged mouse survival by promoting Mct4/Slc16a3 expression and increasing lactate content in the CRC microenvironment, which regulates the accumulation of Treg and MDSCs [82]. The gene discussed is SLC16A3; the disease is colorectal carcinoma.